4P IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+ T-cells
Titel:
4P IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+ T-cells
Auteur:
Ugolini, A. Zizzari, I.G. Ceccarelli, F. Botticelli, A. Colasanti, T. Strigari, L. Rughetti, A. Rahimi, H. Conti, F. Valesini, G. Marchetti, P. Nuti, M.